Physician Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bentley Pharmaceuticals, Inc.
U.K. approves marketing of generic omeprazole
June 22nd, 2005
Bentley Pharmaceuticals, Inc., (BNT), a technology-based specialty pharmaceutical and drug delivery company with a growing branded and generic product line in Europe, announced that its 20 mg generic dosage version of omeprazole has been approved for marketing in the U.K. Omeprazole belongs to a class of proton-pump inhibitors used in the treatment of acid-related gastrointestinal disorders. The product is marketed by Astra Zeneca in Europe under the trade name Losec and in the U.S. under the trade name Prilosec. The company has entered into agreements with multiple distributors and has licensed the product through its Spanish subsidiary, pending...
Source: Physician Law Weekly (2005-06-22)
|
